FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to the pharmaceutical industry in particular to a pharmaceutical composition having anti-tumor activity. Pharmaceutical composition is proposed, in the form of solid capsules of two formulations based on micronized indole-3-carbinol and auxiliary substances in the following ratios, g/capsule: indole-3 carbinol 0.15–0.200, lactose 0.110–0.140, microcrystalline cellulose 0.034–0.064, corn starch modified Starch 1500 0.06–0.095, salts of stearic acid calcium or magnesium – 0.001–0.04, sodium starch glycolate – 0.03–0.05 or croscarmellose sodium – 0.030–0.004.
EFFECT: implementation of the invention provides the preparation of a medicament that increases the therapeutic efficacy of indole-3-carbinol by increasing bioavailability.
4 cl, 1 dwg, 4 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID ORAL DOSAGE FORM OF INDOLE-3-CARBINOL | 2022 |
|
RU2787538C1 |
| METHOD OF PRODUCING A PHARMACEUTICAL ERYTHROMYCIN COMPOSITION | 2015 |
|
RU2600924C1 |
| METHOD OF PRODUCING PHARMACEUTICAL COMPOSITION ADEMETIONINE AND DOSAGE FORM THEREOF | 2015 |
|
RU2587331C1 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATING CEREBROVASCULAR DISORDERS AND METHODS FOR PREPARING THEM | 2012 |
|
RU2559776C2 |
| PHARMACEUTICAL ANTIFUNGAL COMPOSITION BASED ON A CHLOROPHENYLBUTANEDIONE DERIVATIVE AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2707286C1 |
| PHARMACEUTICAL ANTI-DIABETIC COMPOSITION BASED ON SUBSTITUTED THIOPHENE CARBOXYLATE AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2688235C1 |
| DRUG PREPARATION BASED ON INDOLE-3-CARBINOL WITH INCREASED EPIGENETIC ACTIVITY | 2015 |
|
RU2601893C1 |
| ORAL PHARMACEUTICAL COMPOSITION OF DIURETICS AND ACE INHIBITOR IN MICRONIZED FORM, DRUG AND ITS APPLICATION | 2012 |
|
RU2618471C2 |
| STABLE PHARMACEUTICAL PREPARATION CONTAINING AMLODIPINE BENZYLATE AND ATENOLOL | 1998 |
|
RU2188636C2 |
| PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS OBTAINING (VARIANTS) | 1992 |
|
RU2106145C1 |
